Polymyalgia rheumatica physical examination

Revision as of 18:46, 20 April 2018 by Aelsaiey (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Polymyalgia Rheumatica Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polymyalgia rheumatica from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polymyalgia rheumatica physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polymyalgia rheumatica physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polymyalgia rheumatica physical examination

CDC on Polymyalgia rheumatica physical examination

Polymyalgia rheumatica physical examination in the news

Blogs on Polymyalgia rheumatica physical examination

Directions to Hospitals Treating Polymyalgia rheumatica

Risk calculators and risk factors for Polymyalgia rheumatica physical examination

Overview

Physical Examination

Physical examination of patients with polymyalgia rheumatica reveals limitation of the active and passive range of motion of the affected joint. There is no true muscle weakness.[1] There are no changes in the joints.

Appearance of the patients

  • Patients with polymyalgia rheumatica usually appear in pain.

References

  1. Salvarani C, Cantini F, Hunder GG (2008). "Polymyalgia rheumatica and giant-cell arteritis". Lancet. 372 (9634): 234–45. doi:10.1016/S0140-6736(08)61077-6. PMID 18640460.

Template:WH Template:WS